Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma

[1] Cronin KA(2018)Annual report to the nation on the status of Cancer, part I: national cancer statistics Cancer 124 2785-2800

[2] Lake AJ(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424

[3] Scott S(2019)Immunotherapy for hepatocellular carcinoma Cancer Lett 470 8-17

[4] Sherman RL(2019)Identification of a subtype of hepatocellular carcinoma with poor prognosis based on expression of genes within the glucose metabolic pathway Cancers 11 2023-137

[5] Noone AM(2018)Expansile invasive growth pattern is definite evidence for the diagnosis of small hepatocellular carcinomas: a comparative study of 37 cases Hum Pathol 80 130-4958

[6] Howlader N(2019)An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma Peer J 7 e7836-378

[7] Henley SJ(2017)Challenges and opportunities in adapting clinical trial Design for Immunotherapies Clin Cancer Res 23 4950-608

[8] Anderson RN(2019)Rationale of immunotherapy in hepatocellular carcinoma and its potential biomarkers Cancers 11 1926-501

[9] Firth AU(2019)Prolonged tumor response associated with sequential immune checkpoint inhibitor combination treatment and regorafenib in a patient with advanced pretreated hepatocellular carcinoma J Gastrointest Oncol 10 373-1119.e1110

[10] Ma J(2019)The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma Cancer Immunol Immunother 68 599-7191

[1] Cronin KA(2018)Annual report to the nation on the status of Cancer, part I: national cancer statistics Cancer 124 2785-2800

[2] Lake AJ(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424

[3] Scott S(2019)Immunotherapy for hepatocellular carcinoma Cancer Lett 470 8-17

[4] Sherman RL(2019)Identification of a subtype of hepatocellular carcinoma with poor prognosis based on expression of genes within the glucose metabolic pathway Cancers 11 2023-137

[5] Noone AM(2018)Expansile invasive growth pattern is definite evidence for the diagnosis of small hepatocellular carcinomas: a comparative study of 37 cases Hum Pathol 80 130-4958

[6] Howlader N(2019)An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma Peer J 7 e7836-378

[7] Henley SJ(2017)Challenges and opportunities in adapting clinical trial Design for Immunotherapies Clin Cancer Res 23 4950-608

[8] Anderson RN(2019)Rationale of immunotherapy in hepatocellular carcinoma and its potential biomarkers Cancers 11 1926-501

[9] Firth AU(2019)Prolonged tumor response associated with sequential immune checkpoint inhibitor combination treatment and regorafenib in a patient with advanced pretreated hepatocellular carcinoma J Gastrointest Oncol 10 373-1119.e1110

[10] Ma J(2019)The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma Cancer Immunol Immunother 68 599-7191